Emergent BioSolutions Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Emergent BioSolutions Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue1.041.051.081.641.581.110.78
Cost of Revenue0.730.800.690.750.710.430.32
Gross Profit0.310.250.380.890.860.670.46
Operating Expenses
Research & Development0.070.110.190.240.230.230.14
Selling, General & Administrative0.300.360.340.350.300.270.20
Operating Expenses0.360.420.550.510.360.990.37
Operating Income-0.05-0.17-0.170.380.500.110.09
Other Income/Expense
Interest Income0.000.000.000.000.000.000.00
Interest Expense-0.07-0.090.040.03-0.030.000.01
Other Income/Expense0.010.01-0.02-0.050.000.000.00
Income
Income Before Tax-0.14-0.73-0.220.300.410.080.08
Income Tax Expense0.050.03-0.010.080.110.020.02
Net Income-0.19-0.76-0.210.220.310.050.06
Net Income - Continuous Operations-0.19-0.76-0.210.220.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA0.05-0.05-0.040.460.610.230.15
EBIT-0.05-0.17-0.180.340.500.120.09
Depreciation & Amortization0.110.120.060.060.110.060.03
Earnings Per Share
Basic EPS-4.00-15.00-4.004.006.001.001.00
Diluted EPS-4.00-15.00-4.004.006.001.001.00
Basic Shares Outstanding0.050.050.050.050.050.050.05
Diluted Shares Outstanding0.050.050.050.050.050.050.05